泰林生物收盘下跌2.78%，滚动市盈率210.40倍，总市值20.35亿元

Company Overview - Zhejiang Tailin Biological Technology Co., Ltd. specializes in the research, production, and sales of microbiological detection systems, environmental biological pollution control equipment, and total organic carbon analyzers [1] - The main products include various consumables, instruments, and equipment related to microbiological detection technology, isolation technology, and sterilization technology [1] - The company has been awarded the "Advanced Collective in Technological Innovation" by the China Pharmaceutical Equipment Industry Association [1] Financial Performance - As of the latest Q3 2024 report, the company achieved an operating income of 242 million yuan, representing a year-on-year increase of 19.37% [1] - The net profit for the same period was 11.31 million yuan, showing a year-on-year decrease of 46.91% [1] - The sales gross margin stood at 47.91% [1] Market Position - The company's current stock price is 16.79 yuan, with a decline of 2.78% [1] - The rolling price-to-earnings (PE) ratio is 210.40, significantly higher than the industry average of 45.94 and the industry median of 29.64 [1][2] - Tailin Biological ranks 115th in terms of PE ratio within the medical device industry [1] Institutional Holdings - As of the latest report, 39 institutions hold shares in Tailin Biological, all of which are funds, with a total holding of 650,300 shares valued at 1.1 million yuan [1]